96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode

Tyrosine Kinase Inhibitor Library

A unique collection of 137 tyrosine kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).

Size Price  
Pre-dissolved in DMSO
100uL/well(10mM solution) USD 3400
250uL/well(10mM solution) USD 5000

Customize your library by Cherry Picking.

You can select compounds, quantities, format (dry/solid or DMSO), plate map, and concentration to meet your specific requirement.

Recommended Libraries

  • L1100

    Inhibitor Library

    A unique collection of 1127 inhibitors for high throughput screening (HTS) and high content screening (HCS).

  • L1200

    Kinase Inhibitor Library

    A unique collection of 355 kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).

  • L1300

    FDA-approved Drug Library

    1172 FDA-approved drugs

Product Description

Description & Advantages

    • A unique collection of 137 tyrosine kinase inhibitors for high throughput screening (HTS) and high content screening (HCS)
    • Bioactivity and safety confirmed by preclinical research and clinical trials
    • Some tyrosine kinase inhibitors have been approved by FDA
    • Targets tyrosine kinases such as EGFR, VEGFR, SRC, c-Met and JAK
    • Structurally diverse, medicinally active and cell permeable
    • Rich documentation with structure, IC50 and customer reviews
    • NMR and HPLC to ensure the high purity

Product Details

Formulation: A collection of 137 inhibitors supplied as pre-dissolved DMSO solutions
Container: 96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Stability:
3 months -20°C in DMSO
6 months -80°C in DMSO
Shipping: Blue ice
Packaging: Inert gas

Tyrosine Kinase Inhibitor Library Contents

Download the Tyrosine Kinase Inhibitor Library - XLSX Download the Tyrosine Kinase Inhibitor Library - SDF

Contents are for reference only and are subject to change without notice.

Tyrosine Kinase Inhibitor Library Composition

Kinase Inhibitor Library Composition

Customer Reviews (4)

AS-605240 Review
Click to enlarge
Rating
Source J Biomol Screen,2011, 16, 141-154. Axitinib purchased from Selleck
Method Western blot, Multiplexing VimPro-Fluc-MDA-MB-231 spheroid viability
Cell Lines MDA-MB-231 cells
Concentrations 0-100 μM
Incubation Time 1 h
Results When Vimpro-Fluc activity is downregulated between 50% and 70%, there is significant downregulation of vimentin protein expression. When Vimpro-Fluc downregulation reaches ≥70%, then downregulation of vimentin protein expression is more pronounced. of the modulators tested-U0126, dasatinib, axitinib, and pF2341066-all downregulated Vimpro-Fluc activity by≥70%, which correlated with a significant down-reglation of vimentin protein expression. Finally, dose-response curves were generated with both U0126 (IC50 = 2.5 μM) and axitinib (IC50 = 0.25 μM), demonstrating that these small molecules modulate Vimpro-Fluc activity in a dose-dependent manner, indicating that their respective target(s) and signaling pathways play a significant role in maintaining vimentin expression and possibly mesenchymal homeostasis (Fig. B).

Click to enlarge
Rating
Source J Biomol Screen, 2011, 16, 141-154. Axitinib purchased from Selleck
Method Secondary assay
Cell Lines MDA-MB-231 cells
Concentrations 10 μM
Incubation Time
Results U0126, pF2341066, axitinib, and pKC412 caused significant inhibition of the invasive potential of Mda-Mb-231 spheroids. Conversely, dasatinib, a potent inhibitor of vimentin gene expression, did not significantly alter the invasive potential of MDA-MB-231 spheroids.

Click to enlarge
Rating
Source Int J Proteomics, 2011, Article ID 215496. Afatinib (BIBW2992) purchased from Selleck
Method Nikon inverted-phase microscope
Cell Lines lung tumor cell lines
Concentrations 0.1/1 μM
Incubation Time two weeks
Results Reduction of cell colony size formation was observed by the treatment with the irreversible HER1/2 inhibitor BIBW-2992 in H1975 and H1650 cells as seen when these cells were grown in an anchorage-dependent manner.

Click to enlarge
Rating
Source AACR, 2011, Cediranib (AZD2171) purchased from Selleck
Method Cell viability assay
Cell Lines Ba/F3 cells
Concentrations 0-1000 nM
Incubation Time 72 h
Results Cediranib inhibited the survival of Ba/F3 cell lines expressing the recombinant TEL/kinase domain fusion protein for FGFR1-4 in a dose-dependent manner.

Product Citations (9)

  • (PubMed: 21278786)
  • (PubMed: 21278727)
  • (PubMed: 21060108)
  • (PubMed: 21393174)
  • (PubMed: 21328466)
  • (PubMed: 21457548)
  • (PubMed: 21441104)
  • (PubMed: 21107323)
  • (PubMed: 21156286)

See Other Libraries

Tags: phosphatase inhibitor library